A Hepatitis B With Hepatic Steatosis Study
NCT02392598 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2015-08-05
Summary
This is an epidemiologic study on effect of hepatic steatosis on prognosis and outcomes of patients with chronic hepatitis B.
Conditions
- Hepatitis B, Chronic
- Hepatic Steatosis
Sponsors & Collaborators
-
Unimed Scientific Inc.
collaborator INDUSTRY -
Fatty Liver and Alcoholic Liver Disease Study Group, China
lead OTHER
Principal Investigators
-
Jiangao Fan, MD · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
NCT02965911 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Nonalcoholic Steatohepatitis in Chinese Children
NCT03190538 ·Status: RECRUITING
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
NCT00529204 ·Status: TERMINATED ·Phase: PHASE2
-
Integrated Approaches for Identifying Molecular Targets in Liver Disease
NCT03915002 ·Status: COMPLETED
-
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
NCT02865369 ·Status: UNKNOWN
-
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
NCT05749822 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
COVID-19 in Patients With Chronic Liver Diseases
NCT04439084 ·Status: COMPLETED
-
Statin Impact on Hepatic Decompensation
NCT05563389 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation
NCT00956891 ·Status: COMPLETED
-
Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in Diabetology
NCT05605821 ·Status: NOT_YET_RECRUITING
-
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
NCT06891365 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
NCT01728688 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation
NCT05256979 ·Status: ACTIVE_NOT_RECRUITING
-
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02932449 ·Status: COMPLETED
-
Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease
NCT05200585 ·Status: COMPLETED ·Phase: NA
-
Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
NCT05827146 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
NCT05989958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients
NCT03963921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
NCT02400216 ·Status: COMPLETED
-
6-week Safety and PD Study in Adults With NAFLD
NCT03256526 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
NCT04579874 ·Status: COMPLETED ·Phase: NA
-
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
NCT05129904 ·Status: UNKNOWN